Tower Research Capital (TRC)’s Endologix Inc ELGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-27,808
| Closed | -$22K | – | 5357 |
|
|
2020
Q2 | $22K | Buy |
27,808
+22,704
| +445% | +$19.2K | ﹤0.01% | 3643 |
|
|
2020
Q1 | $4K | Buy |
5,104
+308
| +6% | +$377 | ﹤0.01% | 2430 |
|
|
2019
Q4 | $8K | Buy |
4,796
+1,060
| +28% | +$2.97K | ﹤0.01% | 2487 |
|
|
2019
Q3 | $15K | Buy |
3,736
+596
| +19% | +$3.46K | ﹤0.01% | 2708 |
|
|
2019
Q2 | $23K | Buy |
+3,140
| New | +$21.4K | ﹤0.01% | 2106 |
|
|
2019
Q1 | – | Sell |
-1,977
| Closed | -$14K | – | 4688 |
|
|
2018
Q4 | $14K | Buy |
+1,977
| New | +$22K | ﹤0.01% | 2237 |
|
|
2018
Q3 | – | Sell |
-319
| Closed | -$18K | – | 4558 |
|
|
2018
Q2 | $18K | Buy |
+319
| New | +$16.2K | ﹤0.01% | 2512 |
|
|
2018
Q1 | – | Sell |
-328
| Closed | -$18K | – | 4208 |
|
|
2017
Q4 | $18K | Sell |
328
-1,046
| -76% | -$55.2K | ﹤0.01% | 2171 |
|
|
2017
Q3 | $61K | Buy |
+1,374
| New | +$62.6K | 0.01% | 1797 |
|
|
2017
Q2 | – | Sell |
-92
| Closed | -$7K | – | 3865 |
|
|
2017
Q1 | $7K | Buy |
92
+52
| +130% | +$3.44K | ﹤0.01% | 2056 |
|
|
2016
Q4 | $2K | Buy |
40
+30
| +300% | +$2.75K | ﹤0.01% | 3521 |
|
|
2016
Q3 | $1K | Buy |
+10
| New | +$1.28K | ﹤0.01% | 3456 |
|
|
2016
Q2 | – | Sell |
-41
| Closed | -$3K | – | 5314 |
|
|
2016
Q1 | $3K | Sell |
41
-32
| -44% | -$2.64K | ﹤0.01% | 3230 |
|
|
2015
Q4 | $7K | Sell |
73
-1,186
| -94% | -$127K | ﹤0.01% | 2668 |
|
|
2015
Q3 | $154K | Buy |
1,259
+207
| +20% | +$28.1K | 0.01% | 374 |
|
|
2015
Q2 | $161K | Buy |
1,052
+985
| +1,470% | +$163K | 0.01% | 485 |
|
|
2015
Q1 | $11K | Sell |
67
-10
| -13% | -$1.51K | ﹤0.01% | 2734 |
|
|
2014
Q4 | $12K | Buy |
+77
| New | +$9.61K | ﹤0.01% | 2023 |
|
|
2014
Q3 | – | Sell |
-57
| Closed | -$9K | – | 5139 |
|
|
2014
Q2 | $9K | Sell |
57
-7
| -11% | -$932 | ﹤0.01% | 2475 |
|
|
2014
Q1 | $8K | Buy |
+64
| New | +$9.95K | ﹤0.01% | 2889 |
|
|
2013
Q4 | – | Sell |
-613
| Closed | -$99K | – | 5132 |
|
|
2013
Q3 | $99K | Hold |
613
| – | – | 0.01% | 1306 |
|
|
2013
Q2 | $81K | Buy |
+613
| New | +$86.5K | 0.01% | 620 |
|
Other funds holding ELGX
Tower Research Capital (TRC)'s ELGX Position: Q3 2020 in Review
Tower Research Capital (TRC) sold out of Endologix Inc (ELGX) in Q3 2020, closing a stake of 27,808 shares — an estimated $22K sold.
Tower Research Capital (TRC) first reported a position in ELGX in Q2 2013 and held it in 22 quarters. The position peaked at $161K in Q2 2015. 6 funds tracked by Wall St. Rank hold ELGX as of Q3 2020.
- Tower Research Capital (TRC) reported no remaining Endologix Inc position as of Q3 2020 after selling out during the quarter.
- Tower Research Capital (TRC) sold 27,808 Endologix Inc shares in Q3 2020, an estimated $22K.
- Tower Research Capital (TRC) first reported a position in Endologix Inc in Q2 2013 and held it in 22 quarters.
- Tower Research Capital (TRC)'s Endologix Inc position peaked at $161K in Q2 2015.
- 6 funds tracked by Wall St. Rank held Endologix Inc as of Q3 2020.
Based on Tower Research Capital (TRC)'s 13F filing for Q3 2020, filed 16 Nov 2020.